P
Persist AI
Creating long-acting microsphere drug formulations using automation and machine learning
About Persist AI
Persist AI specializes in the development of microsphere formulations for drug delivery, leveraging AI-driven automation to significantly reduce formulation development time by 50%. The company serves pharmaceutical clients by optimizing drug loading, morphology, and distribution through the creation of up to 500 formulations per month. Persist AI's business model focuses on providing rapid pre-formulation services, completing PLGA microsphere pre-formulation in weeks rather than years. The company generates revenue by offering these specialized services to pharmaceutical companies looking to meet specific in vitro and in vivo drug release targets. With a team backed by over 15 years of expertise in drug formulation, machine learning, and automation, Persist AI is committed to exceeding customer expectations through strong teamwork and a supportive work environment. The company operates as a hybrid remote and local entity, fostering collaboration through annual team-building activities.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- West Sacramento, United States
- Employees
- 33
- Open positions
- None listed
- Dealroom signal
- 66.8/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Core AI, Biotech and Pharma, AI Drug Discovery, AI Applications, YC W23, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2025 | $12M | $48M | Y Combinator · Innospark · MBX Capital · Spero Ventures | ↗ |
| SEED✓Equity / VC | Aug 2023 | $4M | $16M | Innospark Ventures · Pioneer Fund · Fellows Fund · Y Combinator | ↗ |
Growth signals
Latest recorded traffic for Persist AI is 3.5K monthly website visits, down 12.5% over the last three months. Persist AI's team declined 13.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Y Combinator
2048 Ventures
Innospark Ventures
Pioneer Fund
Fellows Fund
Series A11 investors entered at this stage
Spero Ventures
Innospark
MBX Capital
SignalFire
Eli Lilly
Good AI Capital
Purdue Innovates Ventures
Asymmetry Ventures
Ford Street Ventures
Cartography Capital
Shimadzu Future Innovation Fund
Other known investors2 additional known investors
- ARAlex Ren
Purdue Research Foundation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Persist AI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Persist AI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.